Neoantigenics Company
.jpg)
Neoantigenics is a liability company that focuses on developing oncology theranostics.
Funding Status:
Seed
Industry:
Women Cancer Treatment
Estimated Revenue:
$1M to $10M
Headquarters:
Charlottesville, Virginia, United States
Total Funding:
$2 536 862
Last Funding Type:
Seed